Pete Anevski

Exciting news from Monica Chopra, Jeffrey De Flavio, MD, Samantha Adelberg, and the rest of the Auxa Health team as they officially announce their $5.2M Seed round. The team's deep industry expertise and drive for change have led them to solve critical infrastructural friction to providing quality healthcare and adoption of value-based care. Auxa's AI benefit navigation platform is simplifying the complexities of healthcare by streamlining all of the fragmented and siloed data and information to make it actionable in real-time for healthcare organizations. For the 70% of Americans who aren't getting access to the health and social care benefits they deserve, Auxa's solution will be pivotal in enabling equitable care. We're thrilled to partner with co-investors Zeal Capital Partners, AlleyCorp, Laconia, and Chaac Ventures on this journey and look to share many more milestones ahead. Cc K50 Ventures, Ryan Bloomer, Daniel Vásquez, Nick Talwar, Stefanie Ng https://lnkd.in/dPDY7-Db

44

4 Comments

One of my proudest moments as an investor occurred today as Alaffia Health announced its series A because it shows how the Aperture® Venture Capital vision of multi-level, multi-generational #impactinvesting is succeeding in the marketplace. Here’s the model in its most basic form : ✅As diverse fund managers with meaningful capital to allocate, we are changing the VC landscape every day just by doing our day jobs. ✅As Black/Brown investors with ~40 years experience collectively, Aperture GPs have access to talent /excellence that others do not, so our portfolio *organically* is more inclusive by race, gender and geography even while optimizing for financial outcomes (all about the alpha). ✅Our most successful portco’s are using financial #innovation to solve market problems that impact underrepresented demographics and underserved communities. Alaffia Health is a shining example of the impact portion of our overall fund thesis, and we couldn’t be prouder of TJ Ademiluyi and Adun Akanni, MPH, PMP - the dynamic brother-sister founder duo whose vision we have steadfastly supported on their journey. Congratulations to TJ and Adun from William Crowder and myself, as well as the whole Aperture team- Marjorie King Philip McKenzie Yves Louis-Jacques Tanvi Lal Michelle Dhansinghani Lisha Bell Katie Kelly Amy Chung Cindy Chong, CFA Brian Fernandes-Halloran Monroe France Jayden Pantel Darren Herman Evan Wladis Neal Triplett Thomas Scriven Peter Ammon Irina Bit-Babik Tim Milanich Rob Rahbari

38

18 Comments

NEW YORK, April 30, 2024 /PRNewswire/ -- PRISM Consulting Partners, a Florida based healthcare private practice acquisition advisory and consulting company, and Lion Management Services Organization of New York, have partnered to form PRISM Concierge. PRISM Consulting Partners was formed in 2023 by founders Michael Guelcher, David Molle, and Brian Whitman. The three partners have over 60 years combined experience in acquisitions, transitioning practices, and healthcare business development. Lion Management was founded in 2021 by James Vena, a Wall Street veteran with 35 years of value creation and capital investment experience. Lion Management implements and manages strategic solutions for private healthcare practices. The newly formed PRISM Concierge aims to be a full-service provider to private healthcare practitioners looking for options ranging from maximizing profit to ultimately transitioning to their desired outcome. The client receives management of back-office services tailored to achieve that outcome. "PRISM Concierge offers the mechanisms and resources to achieve a higher level of freedom," states Michael Guelcher, PRISM Partner. "Change readiness encompasses discipline now, for more freedom and greater rewards later." David Molle goes on to state, "We're filling a void in the healthcare market by bringing together shared resources and services that will ultimately improve a practice's bottom line, while freeing up time to allow for better patient care. Essentially, we're doing the things Drs. don't get paid to do. From shared billing and credentialling, to consultants, attorneys, IT, HR, and a complete group purchasing organization to name a few, your "concierge" can help with most aspects of your business as a single point of contact." James Vena, CEO, Lion Management is enthused about the impact PRISM Concierge can have in the marketplace. "Our recent success of organizing a group of 20 practices in a short window and making them the 35th largest eyecare practice in just two years translates well. We are embarking on something that has never been done before, and there is considerable demand for these services." About PRISM Consulting: https://lnkd.in/ed3gHdVd About Lion Management Services https://lnkd.in/ei-cpseE https://lnkd.in/ei-cpseE #eyecare #privateequity #healthcare #eyewear #optometrist #exits #mso #managementservices

10

4 Comments

A series for those interested in listening to transformational healthcare

2

This article by the WSJ is critically important for public health officials and HealthTech entrepreneurs to internalize. We need multiple solutions for patients to move towards post GLP-1 usage. These solutions need to be easy to implement, non-disruptive to daily life and focused on caloric restriction , lifestyle change and muscle gain. Too many startups are still focused on GLP-1 prescription and delivery. Not enough people focused on the next stage of the weight management journey. As the Journal states, the benefits of the GLP-1 craze are only going to be successful long term if the transition off of them is successful. Otherwise, we risk unforeseen, long term consequences to a large group of patients stuck on GLP-1's with no healthy way to transition off. https://lnkd.in/dYBd3HaN Meghan FitzGerald James Stearns Dominic Perks John LaMattina Raju Kucherlapati

29

2 Comments

The opioid crisis was a sad hallmark of my years working for the Baker Administration. In a time of extreme partisanship at the federal level, this was one area where public policy, civil discourse, and private enterprise seemed aligned and sufficiently motivated to find a solution. What we learned, however, is that dollars and access only go so far in combatting a disease that knows no so specific demographic. Instead, it's apparent that a battery of tools is needed to combat and prevent addiction--ranging from strong safety nets, to novel non-addictive pain therapies, and better technology. Introducing Marigold Health. Shrenik Jain, Ravi Shah, Tracey Cohen, MD, FASAM and team have built a proprietary NLP-based platform that--most significantly--improves the lives of those suffering from SUD/SMI. One customer we spoke with noted, "We needed a unique treatment intervention that had supportive research, fit into a CMS established model with a recognized service code, and that would provide positive clinical outcomes in an efficacious and fiscally responsible manner”. Another plainly said: "Marigold is our best hope to reach into the lives and help those who many have already given up on." Honored to join Bill Evans, Sean Day, and the entire syndicate in doing our part to scale a tool we believe will become essential in the fight against addiction. Marigold Health Innospark Ventures Rock Health KdT Ventures Matt Fates Lily Zarrella Venkat Srinivasan

49

1 Comment

Today I announced that Maelle Gavet, Techstars CEO, will be leaving the company at the end of the month for health reasons and that I have returned as CEO. Over the past three and a half years, we have accomplished a great deal under Maëlle’s leadership. The company has made 2,000+ startup investments. In 2023, 469 Techstars portfolio companies raised a total of over $2.4B, with 322 of them raising rounds of $1M or more. Applications to our programs doubled between 2022 and 2023 while our quality filter has remained as high as ever – an average of just 3% of those applicants were accepted onto our programs. We continue to rate highly with entrepreneurs in our programs, who in 2023 scored Techstars a nine out of 10 for providing business value. All of that while the diversity of our founders rose to 25% female founders and 36% black and brown founders (in 2023).    I want to thank Maëlle for pouring her passion, blood, sweat and tears into Techstars. I feel fortunate to have worked so closely with her. She built a great team, made many tough decisions, and bravely enacted complex changes that were sorely needed. But now Maëlle must focus on her health. I know I speak for everyone at Techstars when I say that we wish her strength and courage as she addresses what's ahead. https://lnkd.in/gNxHZsAk While I am excited to be back as CEO of Techstars, I was never far away. I was the first employee and have been an employee here continuously since then. I was the first Managing Director of our first and at the time, only, accelerator (Boulder) in the early years. In total, I have served as CEO or co-CEO for thirteen of the seventeen years that Techstars has existed and have been on the Board since the company’s inception. Reach out if you have any questions, but in the meantime, I will continue to focus on making Techstars even better for founders!

505

46 Comments

Big news from Karoo Health today. This partnership will accelerate their ability to deliver value based care (VBC) for cardiovascular disease. If you are frustrated with America's healthcare system, VBC will give you reasons to be hopeful. Not only does it drive down costs, but it is better care. Initial data shows 29% of patients using Karoo's model have been diverted from at least one unnecessary ER visit. That's huge savings for our healthcare system and a huge impact on those patients' lives...a true win-win.

13

1 Comment

This week Mikal Ventures brings you a 4-week breakdown of the US capital market with an emphasis on the Mikal verticals. Over the 4-week period ending July 8, 728 new companies were added, resulting in just under 96,400 companies included in the US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. AI Tech maintained its most active status, seeing the greatest percentage of growth in new companies, transactions and news articles. The US Fin Tech vertical led the way in SEC Filings. Mikal Ventures publishes these stats to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

2

1 Comment

Private equity has become an emerging force in healthcare, but to maximize their investment, these firms must prioritize patient experience. Kwasi Nyantakyi, MHA, a Customer Success Manager at Feedtrail, recently walked through how PE firms can measure and improve patient experience to grow patient loyalty, and new acquisition. Read the blog: https://lnkd.in/git-2vnz #healthcareexperience #patientexperience #PX #patientengagement

10

🚨🚨 Thoughtful Analysis Alert 🚨🚨 Why are we seeing significant pullbacks in healthcare services from major retailers like Walmart and Walgreens. This strategic shift underscores the real challenges in healthcare delivery today. Our latest blog post talks about why these pullbacks are happening, the implications, and more. #HealthcareInnovation #RetailHealthcare #StrategicInsights #HealthcareTrends https://lnkd.in/gfW5aX3n

21

1 Comment

According to the latest report from Rock Health, digital health funding in Q1 2024 totaled $2.7B across 133 deals, with an average deal size of $20.6M. It doesn’t break out device-related investments, but most medtech founders I meet these days are being forced to chase tiny rounds made up of endless little checks, consuming valuable energy and slowing their progress. The benign neglect of this next generation of diagnostic and therapeutic devices is counterproductive and surprising. Given the crowded virtual care market, for example, I’d expect more such companies would be exploring medtech partnerships, investments or acquisitions that'd enable them to back integrate into delivering sharper, and more differentiated, care and treatment. This is exactly what Maverix Medical is doing from the other direction: Reshaping the entire spectrum of lung cancer care by integrating more advanced + effective approaches to screening and diagnosis, treatment and therapeutics, and even palliative care…And putting it all to work through an innovative provider network. One notable investor exception is Y Combinator partner Surbhi Sarna who’s been backing great teams like Selera Medical (YC W24) doing foundational work on ambitious medical devices. Without more support from investors like her, we’re going to increasingly find ourselves stuck with the incremental portfolio improvements from the incumbents, and that’s just not nearly enough.

58

5 Comments

Had a blast diving into Amir Dan Rubin's extensive healthcare career on Vital Signs. Amir previously served as the CEO of One Medical and Stanford Health Care, was an EVP at United/Optum and is now the Founding Managing Partner at Healthier Capital. Our conversation spanned payer-provider integrations, lessons learned from leading One Medical, applications of generative AI, and more. Some highlights: ⚡Combining care models We talked a lot about the One Medical/Iora combination. Amir argues that just because two care delivery approaches may occupy the same physical location (e.g., a clinic), that doesn’t mean they necessarily need to conform to the same economic model. For instance, One Medical and Iora were able to combine effectively despite the former being a membership model and the latter being global capitation. Amir emphasizes that much of the overhead resources (e.g., front desk staff, phlebotomy) can be shared across models. ⚡How One Medical uses generative AI to improve efficiency One Medical allows members to message the care team, and then uses NLP to read the message, figure out its content, and triage it to the appropriate team member. Amir is excited about leveraging internal knowledge graphs to get around hallucinations. This approach can point to relevant internal data in helping compose responses, creating more trust and accuracy in the outputs. ⚡Behind the Amazon acquisition One Medical was interested in expanding its direct to consumer offering. However, they recognized that customer acquisition was costly, which is why partnering with Amazon Prime’s existing membership base made sense for them. Amir explains how at their core, both Amazon and One Medical are all about using technology and logistics to create an excellent customer experience. An awesome conversation ranging from health system innovation to startup strategy to health tech investing! Listen to our full episode below: Spotify: https://spoti.fi/3Wrbnol Apple: https://apple.co/3XWOomb

120

7 Comments

Discover 10 big pharma and biotech companies that have spun out their own venture capital arms to invest in startups in the industry. #venturecapital #veteranventures

8

This week Mikal Ventures brings you a 2-week breakdown of the US capital market with an emphasis on the Mikal verticals. Over the 2-week period ending May 13, 450 new companies were added, with just under 95,000 companies included in the US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. AI Tech again saw the greatest percentage of growth in new companies and transactions, weighing in at over double the vertical averages for the period. The US Med Tech vertical led the way in SEC Filings, with Fin Tech leading in news articles. Mikal Ventures publishes these stats to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

4

I’ve realized the power of words in transforming perception and driving results in patient finance. Positioning in-house patient lending as patient financing may not always resonate with providers. Instead, reframing it as managing monthly patient bills and receivables can spark interest. Executing in-house payment loans effectively as receivable management with regulatory compliance can lead to legal interest collection and increased receivable value. #HealthcareFinance #PatientBilling #ReceivableManagement #HealthcareIndustry #Patientfinancing

6

2 Comments

This week Mikal Ventures brings you a 4-week breakdown of the US capital market with an emphasis on the Mikal verticals. Over the 4-week period ending April 15, just over 900 new companies were added, with 94,109 companies included in the US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. AI Tech again saw the greatest percentage of growth in new companies and transactions, weighing in at over double the vertical averages for the period. The US Fin Tech vertical again led the way in SEC Filings and news articles. Mikal Ventures publishes these stats on a rolling 4-week basis to provide a perspective on how the verticals and new startups move through time. We hope you find them informative and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

3

1 Comment